Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches

Frontiers in Microbiology

Volumn 6, Issue OCT, 2015, Pages

  Belizário, José E ^a   Napolitano, Mauro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CRISPR Cas system; Metagenomics; Microbiome; Phage therapy; Pharmacomicrobiomics; Quorum sensing

Indexed keywords

NUCLEAR OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BACTERIAL GENE; BACTERIOPHAGE; BACTEROIDETES; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DIABETES MELLITUS; DIET; DYSBIOSIS; FIRMICUTES; GENE FUNCTION; HUMAN; HUMAN GENOME; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; METAGENOMICS; MICROBIOME; NEXT GENERATION SEQUENCING; NONHUMAN; OBESITY; PROTEOBACTERIA; QUORUM SENSING; REVIEW;

EID: 84946822771     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01050     Document Type: Review

References (162)

1. Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., and Versalovic, J. (2014). The placenta harbors a unique microbiome. Sci. Transl. Med. 6:237ra265. doi: 10.1126/scitranslmed.3008599
2. Abedon, S. T. (2014). Phage therapy: eco-physiological pharmacology. Scientifica (Cairo) 2014:581639. doi: 10.1155/2014/581639
3. Abubucker, S., Segata, N., Goll, J., Schubert, A. M., Izard, J., Cantarel, B. L., et al. (2012). Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 8:e1002358. doi: 10.1371/journal.pcbi.1002358
4. Anukam, K. C., Osazuwa, E., Osemene, G. I., Ehigiagbe, F., Bruce, A. W., and Reid, G. (2006). Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 8, 2772-2776. doi: 10.1016/j.micinf.2006.08.008
5. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., et al. (2011). Enterotypes of the human gut microbiome. Nature 473, 174-180. doi: 10.1038/nature09944
6. Backhed, F., Fraser, C. M., Ringel, Y., Sanders, M. E., Sartor, R. B., Sherman, P. M., et al. (2012). Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12, 611-622. doi: 10.1016/j.chom.2012.10.012
7. Belizario, J. E. (2013). The humankind genome: from genetic diversity to the origin of human diseases. Genome 56, 705-716. doi: 10.1139/gen-2013-0125
8. Bi, D., Xu, Z., Harrison, E. M., Tai, C., Wei, Y., He, X., et al. (2012). ICEberg: a web-based resource for integrative and conjugative elements found in Bacteria. Nucleic Acids Res. 40, D621-D626. doi: 10.1093/nar/gkr846
9. Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., and Marraffini, L. A. (2013). Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 41, 7429-7437. doi: 10.1093/nar/gkt520
10. Brandt, L. J., and Reddy, S. S. (2011). Fecal microbiota transplantation for recurrent Clostridium difficile infection. J. Clin. Gastroenterol. 45(Suppl.), S159-S167. doi: 10.1097/MCG.0b013e318222e603
11. Brown, C. T., Sharon, I., Thomas, B. C., Castelle, C. J., Morowitz, M. J., and Banfield, J. F. (2013). Genome resolved analysis of a premature infant gut microbial community reveals a Varibaculum cambriense genome and a shift towards fermentation-based metabolism during the third week of life. Microbiome 1:30. doi: 10.1186/2049-2618-1-30
12. Brownawell, A. M., Caers, W., Gibson, G. R., Kendall, C. W., Lewis, K. D., Ringel, Y., et al. (2012). Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J. Nutr. 142, 962-974. doi: 10.3945/jn.112.158147
13. Cani, P. D., and Delzenne, N. M. (2011). The gut microbiome as therapeutic target. Pharmacol. Ther. 130, 202-212. doi: 10.1016/j.pharmthera.2011.01.012
14. Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., et al. (2007). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383. doi: 10.1007/s00125-007-0791-0
15. Carr, R., Shen-Orr, S. S., and Borenstein, E. (2013). Reconstructing the genomic content of microbiome taxa through shotgun metagenomic deconvolution. PLoS Comput. Biol. 9:e1003292. doi: 10.1371/journal.pcbi.1003292
16. Chan, B. K., Abedon, S. T., and Loc-Carrillo, C. (2013). Phage cocktails and the future of phage therapy. Future Microbiol 8, 769-783. doi: 10.2217/fmb.13.47
17. Christen, B., Abeliuk, E., Collier, J. M., Kalogeraki, V. S., Passarelli, B., Coller, J. A., et al. (2011). The essential genome of a bacterium. Mol. Syst. Biol. 7:528. doi: 10.1038/msb.2011.58
18. Clemente, J. C., Pehrsson, E. C., Blaser, M. J., Sandhu, K., Gao, Z., Wang, B., et al. (2015). The microbiome of uncontacted Amerindians. Sci. Adv. 1:e1500183. doi: 10.1126/sciadv.1500183
19. Clemente, J. C., Ursell, L. K., Parfrey, L. W., and Knight, R. (2012). The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270. doi: 10.1016/j.cell.2012.01.035
20. Collison, M., Hirt, R. P., Wipat, A., Nakjang, S., Sanseau, P., and Brown, J. R. (2012). Data mining the human gut microbiota for therapeutic targets. Brief. Bioinform. 13, 751-768. doi: 10.1093/bib/bbs002
21. Comeau, A. M., Tetart, F., Trojet, S. N., Prere, M. F., and Krisch, H. M. (2007). Phage-antibiotic synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS ONE 2:e799. doi: 10.1371/journal.pone.0000799
22. Cucchiara, S., Stronati, L., and Aloi, M. (2012). Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease. J. Clin. Gastroenterol. 46(Suppl.), S64-S66. doi: 10.1097/MCG.0b013e31826a857f
23. Culligan, E. P., Sleator, R. D., Marchesi, J. R., and Hill, C. (2014). Metagenomics and novel gene discovery: promise and potential for novel therapeutics. Virulence 5, 399-412. doi: 10.4161/viru.27208
24. Curtis, T. P., Sloan, W. T., and Scannell, J. W. (2002). Estimating prokaryotic diversity and its limits. Proc. Natl. Acad. Sci. U.S.A. 99, 10494-10499. doi: 10.1073/pnas.142680199
25. Dawid, S., Roche, A. M., and Weiser, J. N. (2007). The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo. Infect. Immun. 75, 443-451. doi: 10.1128/IAI.01775-05
26. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., et al. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U.S.A. 107, 14691-14696. doi: 10.1073/pnas.1005963107
27. Defoirdt, T., Boon, N., and Bossier, P. (2010). Can bacteria evolve resistance to quorum sensing disruption? PLoS Pathog. 6:e1000989. doi: 10.1371/journal.ppat.1000989
28. Delaney, M. L., and Onderdonk, A. B. (2001). Nugent score related to vaginal culture in pregnant women. Obstet. Gynecol. 98, 79-84. doi: 10.1016/S0029-7844(01)01402-8
29. Dethlefsen, L., Huse, S., Sogin, M. L., and Relman, D. A. (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280. doi: 10.1371/journal.pbio.0060280
30. DiGiulio, D. B., Romero, R., Amogan, H. P., Kusanovic, J. P., Bik, E. M., Gotsch, F., et al. (2008). Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE 3:e3056. doi: 10.1371/journal.pone.0003056
31. Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., et al. (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 107, 11971-11975. doi: 10.1073/pnas.1002601107
32. Dong, Y. H., and Zhang, L. H. (2005). Quorum sensing and quorum-quenching enzymes. J. Microbiol. 43, 101-109.
33. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., et al. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638. doi: 10.1126/science.1110591
34. Etzold, S., Kober, O. I., Mackenzie, D. A., Tailford, L. E., Gunning, A. P., Walshaw, J., et al. (2014). Structural basis for adaptation of lactobacilli to gastrointestinal mucus. Environ. Microbiol. 16, 888-903. doi: 10.1111/1462-2920.12377
35. Fardini, Y., Chung, P., Dumm, R., Joshi, N., and Han, Y. W. (2010). Transmission of diverse oral bacteria to murine placenta: evidence for the oral microbiome as a potential source of intrauterine infection. Infect. Immun. 78, 1789-1796. doi: 10.1128/IAI.01395-09
36. Fettweis, J. M., Serrano, M. G., Sheth, N. U., Mayer, C. M., Glascock, A. L., Brooks, J. P., et al. (2012). Species-level classification of the vaginal microbiome. BMC Genomics 13(Suppl. 8):S17. doi: 10.1186/1471-2164-13-S8-S17
37. Finch, R. G., Pritchard, D. I., Bycroft, B. W., Williams, P., and Stewart, G. S. (1998). Quorum sensing: a novel target for anti-infective therapy. J. Antimicrob. Chemother. 42, 569-571. doi: 10.1093/jac/42.5.569
38. Flintoft, L. (2012). Disease genomics: associations go metagenome-wide. Nat. Rev. Genet. 13, 756-757. doi: 10.1038/nrg3347
39. Fodor, A. A., DeSantis, T. Z., Wylie, K. M., Badger, J. H., Ye, Y., Hepburn, T., et al. (2012). The "most wanted" taxa from the human microbiome for whole genome sequencing. PLoS ONE 7:e41294. doi: 10.1371/journal.pone.0041294
40. Forsberg, K. J., Patel, S., Gibson, M. K., Lauber, C. L., Knight, R., Fierer, N., et al. (2014). Bacterial phylogeny structures soil resistomes across habitats. Nature 509, 612-616. doi: 10.1038/nature13377
41. Forslund, K., Sunagawa, S., Kultima, J. R., Mende, D. R., Arumugam, M., Typas, A., et al. (2013). Country-specific antibiotic use practices impact the human gut resistome. Genome Res. 23, 1163-1169. doi: 10.1101/gr.155465.113
42. Frantz, A. L., Rogier, E. W., Weber, C. R., Shen, L., Cohen, D. A., Fenton, L. A., et al. (2012). Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol. 5, 501-512. doi: 10.1038/mi.2012.23
43. Fritz, J. V., Desai, M. S., Shah, P., Schneider, J. G., and Wilmes, P. (2013). From meta-omics to causality: experimental models for human microbiome research. Microbiome 1:14. doi: 10.1186/2049-2618-1-14
44. Gareau, M. G., Sherman, P. M., and Walker, W. A. (2010). Probiotics and the gut microbiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 7, 503-514. doi: 10.1038/nrgastro.2010.117
45. Garneau, J. E., Dupuis, M. E., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., et al. (2010). The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67-71. doi: 10.1038/nature09523
46. Gevers, D., Pop, M., Schloss, P. D., and Huttenhower, C. (2012). Bioinformatics for the human microbiome project. PLoS Comput. Biol. 8:e1002779. doi: 10.1371/journal.pcbi.1002779
47. Gomaa, A. A., Klumpe, H. E., Luo, M. L., Selle, K., Barrangou, R., and Beisel, C. L. (2014). Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. MBio 5:e928-13. doi: 10.1128/mBio.00928-13
48. Gough, E., Shaikh, H., and Manges, A. R. (2011). Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994-1002. doi: 10.1093/cid/cir632
49. Grice, E. A., Kong, H. H., Conlan, S., Deming, C. B., Davis, J., Young, A. C., et al. (2009). Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192. doi: 10.1126/science.1171700
50. Groer, M. W., Luciano, A. A., Dishaw, L. J., Ashmeade, T. L., Miller, E., and Gilbert, J. A. (2014). Development of the preterm infant gut microbiome: a research priority. Microbiome 2:38. doi: 10.1186/2049-2618-2-38
51. Guani-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., and Teran, L. M. (2010). Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 135, 1-11. doi: 10.1016/j.clim.2009.12.004
52. Guaraldi, F., and Salvatori, G. (2012). Effect of breast and formula feeding on gut microbiota shaping in newborns. Front. Cell Infect. Microbiol. 2:94. doi: 10.3389/fcimb.2012.00094
53. Guo, F., Ju, F., Cai, L., and Zhang, T. (2013). Taxonomic precision of different hypervariable regions of 16S rRNA gene and annotation methods for functional bacterial groups in biological wastewater treatment. PLoS ONE 8:e76185. doi: 10.1371/journal.pone.0076185
54. Haiser, H. J., and Turnbaugh, P. J. (2012). Is it time for a metagenomic basis of therapeutics? Science 336, 1253-1255. doi: 10.1126/science.1224396
55. Hense, B. A., and Schuster, M. (2015). Core principles of bacterial autoinducer systems. Microbiol. Mol. Biol. Rev. 79, 153-169. doi: 10.1128/MMBR.00024-14
56. Hooper, L. V., Littman, D. R., and Macpherson, A. J. (2012). Interactions between the microbiota and the immune system. Science 336, 1268-1273. doi: 10.1126/science.1223490
57. Human Microbiome Jumpstart Reference Strains, C., Nelson, K. E., Weinstock, G. M., Highlander, S. K., Worley, K. C., Creasy, H. H., et al. (2010). A catalog of reference genomes from the human microbiome. Science 328, 994-999. doi: 10.1126/science.1183605
58. Human Microbiome Project, C. (2012a). A framework for human microbiome research. Nature 486, 215-221. doi: 10.1038/nature11209
59. Human Microbiome Project, C. (2012b). Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214. doi: 10.1038/nature11234
60. Ishikawa, H., Akedo, I., Otani, T., Suzuki, T., Nakamura, T., Takeyama, I., et al. (2005). Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 116, 762-767. doi: 10.1002/ijc.21115
61. Jiang, W., Bikard, D., Cox, D., Zhang, F., and Marraffini, L. A. (2013). RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31, 233-239. doi: 10.1038/nbt.2508
62. Jiang, W., Ling, Z., Lin, X., Chen, Y., Zhang, J., Yu, J., et al. (2014). Pyrosequencing analysis of oral microbiota shifting in various caries states in childhood. Microb. Ecol. 67, 962-969. doi: 10.1007/s00248-014-0372-y
63. Joelsson, A., Liu, Z., and Zhu, J. (2006). Genetic and phenotypic diversity of quorum-sensing systems in clinical and environmental isolates of Vibrio cholerae. Infect. Immun. 74, 1141-1147. doi: 10.1128/IAI.74.2.1141-1147.2006
64. Johnson, C. H., Patterson, A. D., Idle, J. R., and Gonzalez, F. J. (2012). Xenobiotic metabolomics: major impact on the metabolome. Annu. Rev. Pharmacol. Toxicol. 52, 37-56. doi: 10.1146/annurev-pharmtox-010611-134748
65. Jones, B. V., and Marchesi, J. R. (2007). Transposon-aided capture (TRACA) of plasmids resident in the human gut mobile metagenome. Nat. Methods 4, 55-61. doi: 10.1038/nmeth964
66. Kardos, N., and Demain, A. L. (2011). Penicillin: the medicine with the greatest impact on therapeutic outcomes. Appl. Microbiol. Biotechnol. 92, 677-687. doi: 10.1007/s00253-011-3587-6
67. Kayumov, A. R., Khakimullina, E. N., Sharafutdinov, I. S., Trizna, E. Y., Latypova, L. Z., Thi Lien, H., et al. (2014). Inhibition of biofilm formation in Bacillus subtilis by new halogenated furanones. J. Antibiot. (Tokyo) 68, 297-301. doi: 10.1038/ja.2014.143
68. Kenyon, C., Colebunders, R., and Crucitti, T. (2013). The global epidemiology of bacterial vaginosis: a systematic review. Am. J. Obstet. Gynecol. 209, 505-523. doi: 10.1016/j.ajog.2013.05.006
69. Kimura, N. (2014). Metagenomic approaches to understanding phylogenetic diversity in quorum sensing. Virulence 5, 433-442. doi: 10.4161/viru.27850
70. Kootte, R. S., Vrieze, A., Holleman, F., Dallinga-Thie, G. M., Zoetendal, E. G., de Vos, W. M., et al. (2012). The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes. Metab. 14, 112-120. doi: 10.1111/j.1463-1326.2011.01483.x
71. Koren, O., Knights, D., Gonzalez, A., Waldron, L., Segata, N., Knight, R., et al. (2013). A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput. Biol. 9:e1002863. doi: 10.1371/journal.pcbi.1002863
72. Koskella, B., and Meaden, S. (2013). Understanding bacteriophage specificity in natural microbial communities. Viruses 5, 806-823. doi: 10.3390/v5030806
73. Ladizinski, B., McLean, R., Lee, K. C., Elpern, D. J., and Eron, L. (2014). The human skin microbiome. Int. J. Dermatol. 53, 1177-1179. doi: 10.1111/ijd.12609
74. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. (2013). Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546. doi: 10.1038/nature12506
75. Lepage, P., Leclerc, M. C., Joossens, M., Mondot, S., Blottiere, H. M., Raes, J., et al. (2013). A metagenomic insight into our gut's microbiome. Gut 62, 146-158. doi: 10.1136/gutjnl-2011-301805
76. Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon, J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070-11075. doi: 10.1073/pnas.0504978102
77. Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., et al. (2008). Evolution of mammals and their gut microbes. Science 320, 1647-1651. doi: 10.1126/science.1155725
78. Ley, R. E., Turnbaugh, P. J., Klein, S., and Gordon, J. I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023. doi: 10.1038/4441022a
79. Ma, Y., Zhang, L., and Huang, X. (2014). Genome modification by CRISPR/Cas9. FEBS J. 281, 5186-5193. doi: 10.1111/febs.13110
80. Maidak, B. L., Olsen, G. J., Larsen, N., Overbeek, R., McCaughey, M. J., and Woese, C. R. (1996). The ribosomal database project (RDP). Nucleic Acids Res. 24, 82-85. doi: 10.1093/nar/24.1.82
81. Manefield, M., Rasmussen, T. B., Henzter, M., Andersen, J. B., Steinberg, P., Kjelleberg, S., et al. (2002). Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover. Microbiology 148(Pt 4), 1119-1127. doi: 10.1099/00221287-148-4-1119
82. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211. doi: 10.1136/gut.2005.073817
83. Manor, O., and Borenstein, E. (2015). MUSiCC: a marker genes based framework for metagenomic normalization and accurate profiling of gene abundances in the microbiome. Genome Biol. 16:53. doi: 10.1186/s13059-015-0610-8
84. Marchesi, J. R., Sato, T., Weightman, A. J., Martin, T. A., Fry, J. C., Hiom, S. J., et al. (1998). Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA. Appl Environ. Microbiol. 64, 795-799.
85. Marraffini, L. A., and Sontheimer, E. J. (2008). CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322, 1843-1845. doi: 10.1126/science.1165771
86. Mason, M. R., Nagaraja, H. N., Camerlengo, T., Joshi, V., and Kumar, P. S. (2013). Deep sequencing identifies ethnicity-specific bacterial signatures in the oral microbiome. PLoS ONE 8:e77287. doi: 10.1371/journal.pone.0077287
87. Meijer, K., de Vos, P., and Priebe, M. G. (2010). Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr. Opin. Clin. Nutr. Metab. Care 13, 715-721. doi: 10.1097/MCO.0b013e32833eebe5
88. Mekkes, M. C., Weenen, T. C., Brummer, R. J., and Claassen, E. (2014). The development of probiotic treatment in obesity: a review. Benef. Microbes 5, 19-28. doi: 10.3920/BM2012.0069
89. Miller, M. B., and Bassler, B. L. (2001). Quorum sensing in bacteria. Annu. Rev. Microbiol. 55, 165-199. doi: 10.1146/annurev.micro.55.1.165
90. Mobegi, F. M., van Hijum, S. A., Burghout, P., Bootsma, H. J., de Vries, S. P., van der Gaast-de Jongh, C. E., et al. (2014). From microbial gene essentiality to novel antimicrobial drug targets. BMC Genomics 15:958. doi: 10.1186/1471-2164-15-958
91. Montassier, E., Batard, E., Massart, S., Gastinne, T., Carton, T., Caillon, J., et al. (2014). 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation. Microb. Ecol. 67, 690-699. doi: 10.1007/s00248-013-0355-4
92. Mullany, P. (2014). Functional metagenomics for the investigation of antibiotic resistance. Virulence 5, 443-447. doi: 10.4161/viru.28196
93. Nagata, S., Asahara, T., Ohta, T., Yamada, T., Kondo, S., Bian, L., et al. (2011). Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged. Br. J. Nutr. 106, 549-556. doi: 10.1017/S000711451100064X
94. Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M. J., Salcedo, R., Kastenmuller, W., et al. (2012). Compartmentalized control of skin immunity by resident commensals. Science 337, 1115-1119. doi: 10.1126/science.1225152
95. Nealson, K. H., and Hastings, J. W. (1979). Bacterial bioluminescence: its control and ecological significance. Microbiol. Rev. 43, 496-518.
96. Ng, S. C., Hart, A. L., Kamm, M. A., Stagg, A. J., and Knight, S. C. (2009). Mechanisms of action of probiotics: recent advances. Inflamm. Bowel Dis. 15, 300-310. doi: 10.1002/ibd.20602
97. Ng, W. L., and Bassler, B. L. (2009). Bacterial quorum-sensing network architectures. Annu. Rev. Genet. 43, 197-222. doi: 10.1146/annurev-genet-102108-134304
98. Ochsner, U. A., Sun, X., Jarvis, T., Critchley, I., and Janjic, N. (2007). Aminoacyl-tRNA synthetases: essential and still promising targets for new anti-infective agents. Expert Opin. Investig. Drugs 16, 573-593. doi: 10.1517/13543784.16.5.573
99. Ostaff, M. J., Stange, E. F., and Wehkamp, J. (2013). Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol. Med. 5, 1465-1483. doi: 10.1002/emmm.201201773
100. Palmer, D. J., Metcalfe, J., and Prescott, S. L. (2012). Preventing disease in the 21st century: the importance of maternal and early infant diet and nutrition. J. Allergy Clin. Immunol. 130, 733-734. doi: 10.1016/j.jaci.2012.06.038
101. Palmer, K. L., and Gilmore, M. S. (2010). Multidrug-resistant enterococci lack CRISPR-cas. mBio 1:e00227-10. doi: 10.1128/mBio.00227-10
102. Pandey, V., Berwal, V., Solanki, N., and Malik, N. S. (2015). Probiotics: healthy bugs and nourishing elements of diet. J. Int. Soc. Prev. Community Dent. 5, 81-87. doi: 10.4103/2231-0762.155726
103. Papadimitriou, K., Zoumpopoulou, G., Foligne, B., Alexandraki, V., Kazou, M., Pot, B., et al. (2015). Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front. Microbiol. 6:58. doi: 10.3389/fmicb.2015.00058
104. Paredes-Sabja, D., Shen, A., and Sorg, J. A. (2014). Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol. 22, 406-416. doi: 10.1016/j.tim.2014.04.003
105. Parsons, J. B., Broussard, T. C., Bose, J. L., Rosch, J. W., Jackson, P., Subramanian, C., et al. (2014). Identification of a two-component fatty acid kinase responsible for host fatty acid incorporation by Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 111, 10532-10537. doi: 10.1073/pnas.1408797111
106. Perez-Chaparro, P. J., Goncalves, C., Figueiredo, L. C., Faveri, M., Lobao, E., Tamashiro, N., et al. (2014). Newly identified pathogens associated with periodontitis: a systematic review. J. Dent. Res. 93, 846-858. doi: 10.1177/0022034514542468
107. Plagens, A., Richter, H., Charpentier, E., and Randau, L. (2015). DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes. FEMS Microbiol. Rev. 3, 442-463. doi: 10.1093/femsre/fuv019
108. Pruesse, E., Quast, C., Knittel, K., Fuchs, B. M., Ludwig, W., Peplies, J., et al. (2007). SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 35, 7188-7196. doi: 10.1093/nar/gkm864
109. Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., et al. (2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173-1183. doi: 10.1016/j.cell.2013.02.022
110. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65. doi: 10.1038/nature08821
111. Rahman, S. Z., Khan, R. A., Gupta, V., and Uddin, M. (2007). Pharmacoenvironmentology-a component of pharmacovigilance. Environ. Health 6:20. doi: 10.1186/1476-069X-6-20
112. Rasko, D. A., Moreira, C. G., Li de, R., Reading, N. C., Ritchie, J. M., Waldor, M. K., et al. (2008). Targeting QseC signaling and virulence for antibiotic development. Science 321, 1078-1080. doi: 10.1126/science.1160354
113. Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S., McCulle, S. L., et al. (2011). Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4680-4687. doi: 10.1073/pnas.1002611107
114. Reddy, T. B., Thomas, A. D., Stamatis, D., Bertsch, J., Isbandi, M., Jansson, J., et al. (2015). The genomes OnLine Database (GOLD) v.5: a metadata management system based on a four level (meta)genome project classification. Nucleic Acids Res. 43, D1099-D1106. doi: 10.1093/nar/gku950
115. Roberfroid, M. (2007). Prebiotics: the concept revisited. J. Nutr. 137(3 Suppl. 2), 830S-837S.
116. Roberfroid, M. B. (2000). Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr. 71(6 Suppl.), 1682S-1687S.
117. Robinson, C. J., Bohannan, B. J., and Young, V. B. (2010). From structure to function: the ecology of host-associated microbial communities. Microbiol. Mol. Biol. Rev. 74, 453-476. doi: 10.1128/MMBR.00014-10
118. Romero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., et al. (2014). The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2:4. doi: 10.1186/2049-2618-2-4
119. Rosenthal, M., Goldberg, D., Aiello, A., Larson, E., and Foxman, B. (2011). Skin microbiota: microbial community structure and its potential association with health and disease. Infect. Genet. Evol. 11, 839-848. doi: 10.1016/j.meegid.2011.03.022
120. Rouillon, C., Zhou, M., Zhang, J., Politis, A., Beilsten-Edmands, V., Cannone, G., et al. (2013). Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol. Cell. 52, 124-134. doi: 10.1016/j.molcel.2013.08.020
121. Round, J. L., and Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323. doi: 10.1038/nri2515
122. Rupnik, M. (2015). Toward a true bacteriotherapy for Clostridium difficile infection. N. Engl. J. Med. 372, 1566-1568. doi: 10.1056/NEJMcibr1500270
123. Saad, R., Rizkallah, M. R., and Aziz, R. K. (2012). Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes. Gut Pathog. 4:16. doi: 10.1186/1757-4749-4-16
124. Sangiuliano, B., Perez, N. M., Moreira, D. F., and Belizario, J. E. (2014). Cell death-associated molecular-pattern molecules: inflammatory signaling and control. Mediators Inflamm. 2014:821043. doi: 10.1155/2014/821043
125. Sartor, R. B., and Mazmanian, S. K. (2012). Intestinal microbes in inflammatory bowel diseases. Am. J. Gastroenterol. Suppl. 1, 15-21. doi: 10.1038/ajgsup.2012.4
126. Segata, N., Haake, S. K., Mannon, P., Lemon, K. P., Waldron, L., Gevers, D., et al. (2012). Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 13:R42. doi: 10.1186/gb-2012-13-6-r42
127. Selle, K., and Barrangou, R. (2015). Harnessing CRISPR-Cas systems for bacterial genome editing. Trends Microbiol. 23, 225-232. doi: 10.1016/j.tim.2015.01.008
128. Seo, H. S., Xiong, Y. Q., Mitchell, J., Seepersaud, R., Bayer, A. S., and Sullam, P. M. (2010). Bacteriophage lysin mediates the binding of Streptococcus mitis to human platelets through interaction with fibrinogen. PLoS Pathog. 6:e1001047. doi: 10.1371/journal.ppat.1001047
129. Slavin, J. (2013). Fiber and prebiotics: mechanisms and health benefits. Nutrients 5, 1417-1435. doi: 10.3390/nu5041417
130. Smillie, C. S., Smith, M. B., Friedman, J., Cordero, O. X., David, L. A., and Alm, E. J. (2011). Ecology drives a global network of gene exchange connecting the human microbiome. Nature 480, 241-244. doi: 10.1038/nature10571
131. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L. G., Gratadoux, J. J., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105, 16731-16736. doi: 10.1073/pnas.0804812105
132. Sommer, M. O., and Dantas, G. (2011). Antibiotics and the resistant microbiome. Curr. Opin. Microbiol. 14, 556-563. doi: 10.1016/j.mib.2011.07.005
133. Sulakvelidze, A., Alavidze, Z., and Morris, J. G. (2001). Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649-659. doi: 10.1128/AAC.45.3.649-659.2001
134. Thompson, A. L., Monteagudo-Mera, A., Cadenas, M. B., Lampl, M. L., and Azcarate-Peril, M. A. (2015). Milk-and solid-feeding practices and daycare attendance are associated with differences in bacterial diversity, predominant communities, and metabolic and immune function of the infant gut microbiome. Front. Cell Infect. Microbiol. 5:3. doi: 10.3389/fcimb.2015.00003
135. Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., et al. (2009). A core gut microbiome in obese and lean twins. Nature 457, 480-484. doi: 10.1038/nature07540
136. Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., and Gordon, J. I. (2007). The human microbiome project. Nature 449, 804-810. doi: 10.1038/nature06244
137. van der Oost, J., Westra, E. R., Jackson, R. N., and Wiedenheft, B. (2014). Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 12, 479-492. doi: 10.1038/nrmicro3279
138. van Opijnen, T., Bodi, K. L., and Camilli, A. (2009). Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat. Methods 6, 767-772. doi: 10.1038/nmeth.1377
139. Vercoe, R. B., Chang, J. T., Dy, R. L., Taylor, C., Gristwood, T., Clulow, J. S., et al. (2013). Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet. 9:e1003454. doi: 10.1371/journal.pgen.1003454
140. Verdam, F. J., Fuentes, S., de Jonge, C., Zoetendal, E. G., Erbil, R., Greve, J. W., et al. (2013). Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) 21, E607-E615. doi: 10.1002/oby.20466
141. Vuotto, C., Longo, F., and Donelli, G. (2014). Probiotics to counteract biofilm-associated infections: promising and conflicting data. Int. J. Oral Sci. 6, 189-194. doi: 10.1038/ijos.2014.52
142. Wallace, B. D., and Redinbo, M. R. (2013). The human microbiome is a source of therapeutic drug targets. Curr. Opin. Chem. Biol. 17, 379-384. doi: 10.1016/j.cbpa.2013.04.011
143. Wang, G. (2014). Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) 7, 545-594. doi: 10.3390/ph7050545
144. Waters, C. M., and Bassler, B. L. (2005). Quorum sensing: cell-to-cell communication in bacteria. Annu. Rev. Cell Dev. Biol. 21, 319-346. doi: 10.1146/annurev.cellbio.21.012704.131001
145. Whelan, K., and Quigley, E. M. (2013). Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr. Opin. Gastroenterol. 29, 184-189. doi: 10.1097/MOG.0b013e32835d7bba
146. Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., et al. (2009). Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. U.S.A. 106, 3698-3703. doi: 10.1073/pnas.0812874106
147. Wilson, I. D., and Nicholson, J. K. (2009). The role of gut microbiota in drug response. Curr. Pharm. Des. 15, 1519-1523. doi: 10.2174/138161209788168173
148. Woese, C. R. (1987). Bacterial evolution. Microbiol. Rev. 51, 221-271.
149. Woese, C. R., Kandler, O., and Wheelis, M. L. (1990). Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc. Natl. Acad. Sci. U.S.A. 87, 4576-4579. doi: 10.1073/pnas.87.12.4576
150. Wooley, J. C., Godzik, A., and Friedberg, I. (2010). A primer on metagenomics. PLoS Comput. Biol. 6:e1000667. doi: 10.1371/journal.pcbi.1000667
151. Wozniak, R. A., and Waldor, M. K. (2010). Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat. Rev. Microbiol. 8, 552-563. doi: 10.1038/nrmicro2382
152. Wright, G. D. (2010). Antibiotic resistance in the environment: a link to the clinic? Curr. Opin. Microbiol. 13, 589-594. doi: 10.1016/j.mib.2010.08.005
153. Xavier, K. B., and Bassler, B. L. (2003). LuxS quorum sensing: more than just a numbers game. Curr. Opin. Microbiol. 6, 191-197. doi: 10.1016/S1369-5274(03)00028-6
154. Xiao-Jie, L., Hui-Ying, X., Zun-Ping, K., Jin-Lian, C., and Li-Juan, J. (2015). CRISPR-Cas9: a new and promising player in gene therapy. J. Med. Genet. 52, 289-296. doi: 10.1136/jmedgenet-2014-102968
155. Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., et al. (2012). Human gut microbiome viewed across age and geography. Nature 486, 222-227. doi: 10.1038/nature11053
156. Yosef, I., Manor, M., Kiro, R., and Qimron, U. (2015). Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc. Natl. Acad. Sci. U.S.A. 112, 7267-7272. doi: 10.1073/pnas.1500107112
157. Zaura, E., Nicu, E. A., Krom, B. P., and Keijser, B. J. (2014). Acquiring and maintaining a normal oral microbiome: current perspective. Front. Cell Infect. Microbiol. 4:85. doi: 10.3389/fcimb.2014.00085
158. Zhang, Q., Rho, M., Tang, H., Doak, T. G., and Ye, Y. (2013). CRISPR-Cas systems target a diverse collection of invasive mobile genetic elements in human microbiomes. Genome Biol. 14, R40. doi: 10.1186/gb-2013-14-4-r40
159. Zhou, Y., Gao, H., Mihindukulasuriya, K. A., La Rosa, P. S., Wylie, K. M., Vishnivetskaya, T., et al. (2013). Biogeography of the ecosystems of the healthy human body. Genome Biol. 14:R1. doi: 10.1186/gb-2013-14-1-r1
160. Zhou, Y., Mihindukulasuriya, K. A., Gao, H., La Rosa, P. S., Wylie, K. M., Martin, J. C., et al. (2014). Exploration of bacterial community classes in major human habitats. Genome Biol. 15, R66. doi: 10.1186/gb-2014-15-5-r66
161. Zoetendal, E. G., Rajilic-Stojanovic, M., and de Vos, W. M. (2008). High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615. doi: 10.1136/gut.2007.133603
162. Zomer, A., Burghout, P., Bootsma, H. J., Hermans, P. W., and van Hijum, S. A. (2012). ESSENTIALS: software for rapid analysis of high throughput transposon insertion sequencing data. PLoS ONE 7:e43012. doi: 10.1371/journal.pone.0043012